Investigators have shown that certain screening methods that detect the genetic material of Zika virus can be used to ensure that donated blood supplies remain free of the virus.
The methods, called Zika virus nucleic acid amplification technology assays, demonstrated similar excellent sensitivities to assays currently used for screening for transfusion-transmitted viruses. The methods were substantially more sensitive than most other laboratory-developed and diagnostic Zika virus assays.